Pinnacle Financial Partners (Tennessee)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$23K	–	461
2025 Q2	$23K	Hold	1,000	–	–	﹤0.01%	489
2025 Q1	$37.1K	Hold	1,000	–	–	﹤0.01%	493
2024 Q4	$48.5K	Hold	1,000	–	–	﹤0.01%	481
2024 Q3	$48.5K	Hold	1,000	–	–	﹤0.01%	480
2024 Q2	$43.9K	Hold	1,000	–	–	﹤0.01%	484
2024 Q1	$43.9K	Hold	1,000	–	–	﹤0.01%	479
2023 Q4	$61.9K	Hold	1,000	–	–	﹤0.01%	451
2023 Q3	$46K	Hold	1,000	–	–	﹤0.01%	435
2023 Q2	$57.5K	Hold	1,000	–	–	﹤0.01%	434
2023 Q1	$37.5K	Hold	1,000	–	–	﹤0.01%	446
2022 Q4	$28K	Hold	1,000	–	–	﹤0.01%	447
2022 Q3	$28K	Hold	1,000	–	–	﹤0.01%	437
2022 Q2	$35K	Hold	1,000	–	–	﹤0.01%	387
2022 Q1	$36K	Hold	1,000	–	–	﹤0.01%	399
2021 Q4	$23K	Hold	1,000	–	–	﹤0.01%	437
2021 Q3	$19K	Hold	1,000	–	–	﹤0.01%	438
2021 Q2	$20K	Hold	1,000	–	–	﹤0.01%	440
2021 Q1	$20K	Hold	1,000	–	–	﹤0.01%	391
2020 Q4	$19K	Hold	1,000	–	–	﹤0.01%	393
2020 Q3	$19K	Hold	1,000	–	–	﹤0.01%	385
2020 Q2	$22K	Hold	1,000	–	–	﹤0.01%	370
2020 Q1	$15K	Hold	1,000	–	–	﹤0.01%	377
2019 Q4	$19K	Buy	+1,000	New	+$19.2K	﹤0.01%	415
2019 Q2	–	Sell	-1,000	Closed	-$20K	–	351
2019 Q1	$20K	Buy	+1,000	New	+$22.4K	﹤0.01%	383
2018 Q4	–	Sell	-1,000	Closed	-$19K	–	320
2018 Q3	$19K	Hold	1,000	–	–	﹤0.01%	394
2018 Q2	$15K	Hold	1,000	–	–	﹤0.01%	371
2018 Q1	$19K	Buy	+1,000	New	+$18.8K	﹤0.01%	368

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s AMPH Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 1,000 shares — an estimated $23K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in AMPH in Q1 2018 and held it in 27 quarters. The position peaked at $61.9K in Q4 2023. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

Pinnacle Financial Partners (Tennessee) reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Pinnacle Financial Partners (Tennessee) sold 1,000 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $23K.
Pinnacle Financial Partners (Tennessee) first reported a position in Amphastar Pharmaceuticals in Q1 2018 and held it in 27 quarters.
Pinnacle Financial Partners (Tennessee)'s Amphastar Pharmaceuticals position peaked at $61.9K in Q4 2023.
243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.